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Summary.-In a retrospective study we have used an immunoperoxidase procedure
to localize the glycoprotein fibronectin in human rectal carcinomas, concentrating
on tumour invading thick-walled extramural veins. Fibronectin was present in 29
out of38 cases, in connective tissue stroma, and was not in direct association with the
tumour cells, except in areas of necrosis. We found no correlation between the
presence or absence ofstromal fibronectin and (1) the degree ofcellular differentiation
within the tumour, (2) tumour progression (Dukes' classification) (3) the subsequent
development of metastases and (4) patient longevity. Our results do not support
the conclusions from in vitro studies (Smith et al., 1979) that the metastatic potential
of carcinomas may be partly determined by the ability of tumour cells to synthesize
pericellular fibronectin.
CURRENT INTEREST in the high-mol.-wt
glycoprotein fibronectin stems from the
observation that, whilst it is associated
with the surface of a variety of normal
cell lines in culture, particularly those of
mesenchymal origin, it is largely absent
from their tumour-virus-transformed deri-
vatives (Hynes et al., 1978; Yamada &
Olden, 1978). The relationship between
loss of surface fibronectin and other
characteristics of the transformed pheno-
type (e.g. rounded morphology, loss of
contact inhibition) is now clear, and
relates to the role of fibronectin as a
matrix component important for cell
adhesion (Ruoslahti et al., 1981; Kleinman
et al., 1981). However, the correlation, if
any, between loss offibronectin in vitro and
increased tumorigenic potential of trans-
formed cells in vivo has been the subject
of conflicting reports (Chen et al., 1976;
Gallimore et al., 1979; Der & Stanbridge
1978, 1980; Kahn & Shin 1979). In a
recent study, Smith et al. (1979) found that
human epithelial cell lines derived from
primary carcinomas or non-malignant
tissues showed extensive deposition of
matrix fibronectin, whereas lines from
metastatic carcinomas expressed little
such material. One interpretation of these
findings is that a better correlation exists
between loss of fibronectin and increased
metastatic potential than with tumori-
genicity per se. However, the need to
examine human tumour material directly
and avoid possible artifacts generated
by taking cells into culture is obvious.
In a previous study of carcinoma of
rectum, Talbot et al. (1980) showed that
primary adenocarcinoma was invading
rectal veins in 520% of 703 cases. The
prognosis was found to depend on the
extent of venous invasion, and was
particularly poor when there was spread
of tumour into large (thick-walled) extra-
mural veins (Talbot et al., 1981). However,
15/91 patients with this type of extensive
venous invasion did in fact survive for
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5 years, indicating that spread of the
primary tumour into veins cannot be
regarded as an invariably sinister event.
Whether this is because of variation in
the intrinsic nature of the invading
adenocarcinoma or due to variation in
reactivity ofthe host tissues atthe primary
or potential secondary sites is unclear.
One possibility is that the adhesiveness
and cohesion of the adenocarcinoma cells
within invaded veins is greater in some
tumours than in others. Because of the
suggestions from in vitro evidence that
cell adhesion is mediated by fibronectin
we decided to examine tissue from the
cases of rectal adenocarcinoma previously
investigated by Talbot et al. (1980, 1981)
to determine whether any correlation
exists between the absence of fibronectin
from tumour within extramural veins,
metastatic spread and patient longevity.
MATERIALS AND METHODS
Tissue sections8.-Five-/utm paraffin sections
were cut from blocks of the same cases
of surgically excised rectal adenocarcinoma
that w%Nere previously investigated by Talbot
et al. (1980, 1981). Only those blocks which
included invasion of thick-walled extra-
mural veins by the tumour were studied.
(The material is held at the Department
ofPathology, St Mark's Hospital, London.)
Anti-serum to human plasma fibronectin.-
Fibronectin w%as purified from outdated
citrated human plasma by gelatin-Sepharose
chromatography (Engvall & Ruoslahti, 1977)
followed by preparative SDS-polyacrylamide-
gel electrophoresis. The protein recovered by
electroelution gave a single band on 700
SDS-polyacrylamide gels. Rabbits were in-
jected s.c. with 1 mg of fibronectin in com-
plete Freund's adjuvant, followed by 2
booster injections (0.5 mg each) at 2-week
intervals. The animals were bled 10 days
later, and the antiserum characterized by
immunodiffusion and immunoelectrophoresis.
Whilst the antiserum cross-reacted with both
urea-eluted and arginine-eluted fibronectin.
as well as with human plasma, it did not
cross-react with human serum albumin.
fibrinogen, fibronectin-depleted plasma or
gelatin. Anti-fibronectin antibodies were
subsequently purified by affinity chromato-
graphy on a fibronectin-Sepharose column,
as described by Yamada (1978).
Immunohistochemical localization of fibro-
nectin. Sections of biopsy material were
stained for fibronectin using a 3-layered-
bridge technique with a peroxidase anti-
peroxidase (PAP) complex (Sternberger et al.,
1970). Some of the improvements suggested
by Strauss (1979) were used, including the
use of phenylhydrazine to block endogenous
peroxidase activity, and 01M imidazole
buffer (pH 7.0) to improve the staining with
3,4,3'4', tetra-aminobiphenyl hydrochloride.
In addition, normal serum from the species
supplying the secondary antibody (swine)
was used to block nonspecific tissue-binding
sites as suggested by De Lellis et al. (1979).
The swine serum was first depleted of
fibronectin by passage through two gelatin-
Sepharose columns. As the tissues had been
fixed in formalin, all sections were treated
with trypsin to unmask potential antigenic
sites (Brozman, 1978), though pilot experi-
ments showed that this step did not affect
the intensity of the staining for fibronectin.
Staining was optimal with an anti-fibro-
nectin concentration of 50 Hug/ml, and was
quantitatively removed by adsorbing the
antibody with fibronectin. There was no
staining in the presence of non-immune
immunoglobulins (50 ,ug/ml). The final stain-
ing protocol adopted is given in Table I.
Sections from each case were stained both
with anti-fibronectin and non-immune immu-
noglobulins to determine the presence or
absence of fibronectin from tumour within
thick-walled extramural veins.
RESULTS
Staining of tumour in thick-walled
extramural veins for fibronectin showed
the following characteristics. Clearly viable
tumour cells were generally substantially
unstained for fibronectin, though occasion-
al cells showed definite positive staining.
There was no evidence that tumour cells
were associated with a pericellular matrix
of fibronectin (Fig. 1). In contrast,
necrotic cells, when present, gave strong
positive staining for fibronectin, whilst
the corresponding control sections were
uniformly negative. The bulk of the
fibronectin was generally associated with
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TABLE I.-Procedure for immunohisto-
chemical localization offibronectin
(1) Sequential passage of sections through xylene
and ethanol to PBS.
(2) 0.1% w/v trypsin in PBS; 30 min.
(3) 10% w/v/ phenylhydrazine; 60 min, 37°C.
(4) Normal swine serum (1:3 dilution); 15 min.
(5) Rabbit anti-fibronectin (50 ,tg/ml); 60 min.
(6) Swine anti-rabbit immunoglobulin* (1:20 dilu-
tion); 30 min.
(7) PAP complex* (1:100 dilution); 30 min.
(8) 0.05%o w/v tetra-aminobiphenyl HCI in 0 IM
imidazole, 0.3 o H202; 5 min.
(9) Counterstain with Mayer's haemotoxylin.
Note: All consecutive stages are separated by
extensive washing in PBS. All procedures carried
out at room temperature unless otherwise stated.
*Purchased from Dako, Denmark.
....
(13)~~~~~~~~~~~~~~~~~~~~~~~1
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FIG. 1.-(A) Portions ofadenocarcinoma from
within a vein, stained by the PAP pro-
cedure after applying anti-fibronectin
serum. The fibrous-tissue stroma surround-
ing the tumour and the necrotic central
areas of the tumour are strongly and
specifically stained. The viable adeno-
carcinoma cells are negative, though
some columnar cells, of doubtful viability,
are positive (original magnification x 25).
(B) Parallel section to (A), stained by the
same procedure, substituting pre-immune
rabbit serum (mirror image).
the connective tissue stroma, which was
always present (Fig. 1), thoughthe amount
in the individual cases was variable.
The relationship between stromal stain-
ing for fibronectin and the histological
grade (degree of differentiation) of the
tumours is shown in Table II. About
76% of moderately differentiated tumours
(Grade 2) contained fibronectin-positive
TABLE II.-Relationship between stromal
fibronectin and histological grade in 41






+ 0 19 12
1 6 3
* Grade 1 =well differentiated tumour (WHO
classification; Morson, 1976), Grade 2=moderately
differentiated tumour, Grade 3=poorly differentia-
ted tumour.
stroma, and 80% of poorly differentiated
tumours. There is therefore no obvious
correlation between the presence of stro-
mal fibronectin and the level ofdifferentia-
tion of the tumour. Similarly there was
no correlation between presence or absence
of stromal fibronectin and the stage ofthe
tumour (Dukes, 1932) as judged by the
extent of local invasion (Stage B) or
spread of the tumour into the lymph
nodes (Stage C) (Table III). The presence
of stromal fibronectin as it relates to
the development ofmetastases andpatient
survival is shown in Table IV and Fig. 2.
TABLE III.-Relationship between stromal
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8 7 22 4
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TABLE IV.-Relationship between stromal
fibronectin and subsequent development of
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[A] cases (29) positive
for stromal fibronectin
0-6 7-12 13-1S 19-24 25-36 37-4849-60 .8o
patient survival (in monthsl
[B] coses(9) negative
for stromal fibronectin
Fic. 2.-(A and B) Relationship between
stromal fibronectin and patient survival.
Out of 38 cases of thick-walled venous
invasion, 29 showed tumours which were
positive for stromal fibronectin, yet 22
of these developed metastases (Table IV).
Of the 9 cases in which the tumour
contained no stromal fibronectin, only
4 developed metastases. Analysis of the
databylog-rankcorrelationclearlyshowed
that the absence of stromal fibronectin
is not significantly related to metastatic
spread (P< 0 1), nor to patient survival
(P<01), (Fig. 2).
DISCUSSION
The distribution offibronectin in normal
human rectal mucosa has recently been
examined by Scott et at. (1981) using
immunofluorescence and immuno-peroxi-
dase techniques. The most prominent
staining for fibronectin was found in the
connective tissue of the lamina propria,
though fibronectin was also found in and
around some apical epithelial cells and
in the underlying basement membranes.
In an earlier study, fibronectin was also
found associated with the basement mem-
brane under crypt cells in rat small
intestine (Quaroni et al., 1978). The distri-
bution is consistent with the idea that
fibronectin is important in adhesion of
cells (including epithelial cells) to base-
ment membranes. In the present study
of 40 cases, we have found that viable
adenocarcinoma cells do not generally
show positive staining for fibronectin by
the PAP method, though the occasional
cell or group of cells sometimes show a
frank brown coloration. However, we
cannot exclude the possibility that all
adenocarcinoma cells produce low levels
of fibronectin. The PAP method of
detecting antigens in tissue sections is
acknowledged to be among the most
sensitive techniques available, largely
due to the low levels of background
staining (Sternberger, 1979), though the
absolute sensitivity of the method in
different situations is uncertain. The
above result is consistent with the work
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Vaheri (1981), who found that, although
sarcomas produce fibronectin in vivo,
carcinoma cells do not. The deposition ofa
fibronectin-containing pericellular matrix
would therefore appear to be associated
with tumour cells of mesenchymal rather
than epithelial origin. The strong positive
staining for fibronectin in necrotic cells
is difficult to explain, but would not
appear to be a method artifact. One
possible explanation is that the fibro-
nectin originates from the plasma as a
host measure to opsonize necrotic cells
before phagocytosis by macrophages (Saba
et al., 1980). However, as necrosis is
presumed to be due to ischaemia it is
difficult to see how plasma fibronectin
could reach such a location.
Whilst fibronectin was not generally
associated directly with the tumour cells,
it was found in the connective-tissue
stroma of most of our cases (29/38).
This result agrees with that of Stenman
& Vaheri (1981), who found fibronectin
in the stroma of a variety of carcinomas,
including adenocarcinoma of the colon.
Although fibroblasts are likely to be the
source of this fibronectin, the possibility
that other cell types, including epithelial
cells, contribute this material cannot
be excluded. More detailed information
on the ability of the various cell types
within the tumour to synthesize fibro-
nectin may come from immuno-electron
microscopy. Our results clearly establish
that there is no correlation between this
stromal fibronectin and the level of
differentiation of cells within the tumour,
though fibronectin has been shown to
influence morphology in vitro (Hynes etal.,
1978; Yamada & Olden, 1978) as well as
certain aspects of cellular differentiation
(West et al., 1979; Podleski et al.. 1979).
Tumour progression, metastasis and
patient longevity also failed to correlate
with the presence of stromal fibronectin.
Although loss of adhesiveness has long
been thought important in the invasion
and dissemination of malignant tumours
(Abercrombie & Ambrose, 1962), the
idea that fibronectin within carcinoma-
tous tissue might limit tumour metastasis
through its ability to promote cell ad-
hesion would appear to be incorrect.
Indeed, Vlodavsky&Gospodarowicz (1981)
have recently shown that a colonic-
carcinoma cell line was unable to adhere
to culture dishes coated with fibronectin,
although they were able to attach and
spread on the glycoprotein laminin. The
role of laminin as an adhesive glyco-
protein specific for cells of epithelial
origin has been confirmed in other systems
(Terranova et al., 1980; Kleinman et al.,
1981). These results indicate a need to
re-examine our cases to search for a
correlation between the levels of laminin,
metastasis and patient longevity.
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